[Slowing the age-induced decline of brain function with prophylactic use of (-)-deprenyl (Selegiline, Jumex). Current international view and conclusions 25 years after the Knoll's proposal].

塞莱吉林 预期寿命 医学 帕金森病 单胺氧化酶B 疾病 药理学 内科学 生理学 生物 单胺氧化酶 人口 生物化学 环境卫生
作者
Ildikó Miklya
出处
期刊:PubMed [National Institutes of Health]
卷期号:11 (4): 217-25 被引量:1
链接
标识
摘要

Due primarily to developments in immunology, chemotherapy and hygiene the estimated life expectancy at birth increased during the last century from about 55 years to 80 years. Since the human Technical Life Span (TLSh) is about 120 years and life expectancy is today steadily increasing by about 2.2 months/year, a life span of 100 years may appear quite soon. Knoll developed (-)-deprenyl, the first anti-aging drug, the prophylactic administration of which increased significantly the average life span of animals. (-)-Deprenyl became a world-wide used experimental tool as the first selective inhibitor of B-type MAO and being the unique MAO inhibitor free of the cheese effect was introduced to treat Parkinson's disease, because it could be administered in combination with levodopa without side effects. However, Knoll demonstrated in his later work that (-)-deprenyl has enhancing qualities already in femto-picomolar concentrations, which leave MAO-B activity unchanged, and the activity of the catecholaminergic neurons in the brain stem and this previously unknown 'enhancer effect' is responsible for the peculiar therapeutic benefits caused by (-)-deprenyl. Knoll proposed 25 years ago to slow the aging of the brain, the decay of behavioral performance, prolong life, and prevent or delay the onset of age-related neurodegenerative diseases such as Parkinson's and Alzheimer's via the prophylactic daily administration of 1 mg (-)-deprenyl. At present (-)-deprenyl belongs to the best known anti-aging drugs and a rapidly growing number of people are already trying to slow the aging of their brain by taking (-)-deprenyl as a prophylactic agent. Nevertheless, up to the present, an exact analysis with placebo control of the capacity of (-)-deprenyl to prevent or delay the onset of neurodegenerative diseases is still missing. It is already very much on the map to perform such a study with this world-wide highly esteemed Hungarian drug.

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
orixero应助lyp7028采纳,获得10
刚刚
ohm完成签到,获得积分10
刚刚
情怀应助晚风采纳,获得10
刚刚
科研通AI2S应助晚风采纳,获得10
刚刚
cch关注了科研通微信公众号
1秒前
zz关注了科研通微信公众号
1秒前
丘比特应助晚风采纳,获得10
1秒前
酷波er应助晚风采纳,获得10
1秒前
科研通AI6.2应助晚风采纳,获得30
1秒前
666发布了新的文献求助10
1秒前
包包发布了新的文献求助10
1秒前
英俊的铭应助晚风采纳,获得10
1秒前
周一更发布了新的文献求助30
2秒前
科研通AI2S应助晚风采纳,获得10
2秒前
英姑应助lili采纳,获得10
2秒前
思源应助晚风采纳,获得10
2秒前
行走的荷尔蒙应助晚风采纳,获得30
2秒前
蓝凌韵完成签到,获得积分10
2秒前
3秒前
4秒前
凶狠的八宝粥应助ohm采纳,获得10
4秒前
4秒前
酷波er应助豆豆浆采纳,获得10
5秒前
5秒前
万能图书馆应助陈俊彰采纳,获得10
5秒前
南南发布了新的文献求助10
5秒前
xiwa完成签到,获得积分10
6秒前
6秒前
7秒前
书晗发布了新的文献求助20
7秒前
7秒前
结实煎饼发布了新的文献求助10
8秒前
9秒前
酷炫的毛巾应助晚风采纳,获得10
9秒前
SciGPT应助晚风采纳,获得30
9秒前
9秒前
英姑应助晚风采纳,获得10
9秒前
当街走路里应助晚风采纳,获得30
10秒前
今后应助晚风采纳,获得10
10秒前
enn发布了新的文献求助10
10秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
HYDROLYSE ACIDE DE QUELQUES DIOXASPIROCYCLANES 1000
Navigating Normative Orders. Interdisciplinary Perspectives 800
1 Peter and Christ's Descent to the Dead in Its Early Christian Reception 700
Essentials of Carbohydrate Chemistry and Biochemistry, 4th Edition 600
Organizational Behavior 510
Management and the Arts 510
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 工程类 有机化学 化学工程 生物化学 计算机科学 内科学 物理 复合材料 催化作用 细胞生物学 无机化学 光电子学 物理化学 电极 基因
热门帖子
关注 科研通微信公众号,转发送积分 7741038
求助须知:如何正确求助?哪些是违规求助? 9289533
关于积分的说明 20196239
捐赠科研通 7319208
什么是DOI,文献DOI怎么找? 3306551
关于科研通互助平台的介绍 2458886
邀请新用户注册赠送积分活动 2316899